Diseases · Entity Annotation Prototype (beta)

19articles mentioning diseases

27disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: Non-alcoholic fatty liver disease ×

Non-alcoholic fatty liver disease

This disease is selected. Its supporting articles are shown below.

Non-alcoholic fatty liver disease19

Articles mentioning Non-alcoholic fatty liver disease

19 articles · page 2 of 2

Comparison of the identification and practicability of non-invasive diagnostic indicators under NAFLD, MAFLD and MASLD in China: a cross-sectional study

bmjopen · abstract · 2026-04-02 · 1 matching annotations

88.3%

NAFLD NAFLD-AUROC non-alcoholic fatty liver disease MASLD LAP

…al feasibility of non-invasive diagnostic indicators across the NAFLD, MAFLD and MASLD diagnostic criteria.Design Cross-sectional stu…

Multimorbidity patterns and their associations with healthcare services utilisation in inpatients with chronic hepatitis B infection from 2011 to 2023: a retrospective observational study

bmjopen · abstract · 2026-04-02 · 1 matching annotations

95.5%

non-alcoholic fatty liver disease cirrhosis diabetes mellitus hypertension hepatocellular carcinoma chronic kidney diseases HCC chronic hepatitis B (CHB) infection

…50%–57.10%), hepatocellular carcinoma (HCC) (13.10%–17.10%) and non-alcoholic fatty liver disease (3.15%–5.08%) increased over time. Similar trends were observed…

Using an integrative multi-omics and in vitro approach to investigate the role of tris(2-butoxyethyl) phosphate in promoting hepatic steatosis

bmjgast · abstract · 2026-03-03 · 1 matching annotations

94.3%

non-alcoholic fatty liver disease metabolic dysfunction-associated steatotic liver disease (MASLD)insulin resistance TBOEP

…OEP and MASLD, with enrichment analysis pointing to pathways in non-alcoholic fatty liver disease and insulin resistance. PPI analysis highlighted ACTB, IL6, PPA…

Lipid accumulation product (LAP) index and its relation to anthropometric, metabolic and liver function factors in obese patients with NAFLD: a cross-sectional study

bmjopen · abstract · 2026-02-18 · 1 matching annotations

89.3%

NAFLD non-alcoholic fatty liver disease Tabriz University of Medical Sciences

…also increased in line with higher grades of liver steatosis in NAFLD.…

Effects of timing and eating duration of time restricted eating on metabolic outcomes: systematic review and network meta-analysis

bmjmed · full text · 2026-01-21 · 1 matching annotations

91.8%

Cardiovascular disease ischaemic heart disease type 2 diabetes non-alcoholic fatty liver disease metabolic syndrome cardiovascular diseases Non-communicable diseases PubMed Intermittent fasting self-selected time restricted eating+1 more

…WHAT IS ALREADY KNOWN ON THIS TOPIC Cardiovascular disease is a leading cause of death, with modifiable metabolic risk fac…

Young adults with metabolic dysfunction-associated steatotic liver disease (MASLD): why current services fail – and how we can fix them

flgastro · abstract · 2025-12-31 · 1 matching annotations

90.8%

fatty-liver disease hepatic steatosis non-alcoholic fatty liver disease NAFLD ALSPAC Avon Longitudinal Study of Parents and Children

…One in five young adults in the UK already has fatty-liver disease. In the Avon Longitudinal Study of Parents and Children (ALSPAC…

OP76 Do the harmful effects of obesity differ by socio-economic position? Assessing effect modification using linked UK biobank cohort data

jech · abstract · 2025-08-24 · 1 matching annotations

92.5%

diabetes Obesity sleep apnoea essential hypertension osteoarthritis pancreatitis gout

… by the main effects of obesity and low SEP (TDI tertile) were: diabetes 3.03 (2.66; 3.4), essential hypertension 0.51 (0.43; 0.58), gou…